Search - tctmd.com

Displaying 21 - 40 of 63

Sort: Relevancy | Date

News Conference News EuroPCR 2023

BASILICA, Chimney Stenting: No Clear Winner to Prevent TAVI Coronary Obstruction

Michael O'Riordan

May 16, 2023

News Conference News TCT 2022

Sizing Mismatch a Problem for Balloon-Expandable Valves in Small Annuli TAVI

Yael L. Maxwell

September 18, 2022

Presentation TCT 2022

TCT 742: Device closure of Ruptured Right Coronary Sinus of Valsalva Aneurysm (RSOV) in the subpulmonic right ventricle in an elderly female

Presenter: SANJAY RAJDEV

September 17, 2022

News Daily News

Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’

Michael O'Riordan

July 18, 2022

Presentation TVT 2022

Sinus Sequestration After TAVR With Coronary Protection: Diagnosis and Management

Presenter: Andrea Scotti

June 08, 2022

News Conference News ACC 2022

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Michael O'Riordan

April 04, 2022

Presentation TCT 2021

TCT 696: Coronary sinus reducer transfemoral extraction after intraprocedural device migration to pulmonary artery

Presenter: Alfonso Jurado

November 04, 2021

News Conference News ESC 2021

His-bundle Pacing, TAVI Advice Debut in ESC’s Update to Pacing, CRT Guidelines

Todd Neale

September 01, 2021

News Conference News CRT 2021

Low Mortality and Stroke Rates With BASILICA Pre-TAVI, Registry Shows

Michael O'Riordan

March 09, 2021

News Conference News PCR London Valves 2020

No Angina? No Benefit to PCI Pre-TAVR: ACTIVATION

Shelley Wood

November 26, 2020

News Daily News

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Michael O'Riordan

October 28, 2020

Presentation TCT 2020

TCT 464: Risk of Coronary Obstruction Due to Sinus Sequestration in Repeat Transcatheter Aortic Valve Replacement

Presenter: Tomoki Ochiai

October 14, 2020

News Daily News

Which TAVR Device Is Best? Review Tackles Optimal Selection

Michael O'Riordan

September 09, 2020

News Industry News

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

September 02, 2020

News Industry News

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

February 25, 2020

News Daily News

Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion

Yael L. Maxwell

February 14, 2020

News Daily News

ACS After TAVR a Unique Condition With Poor Prognosis

Todd Neale

February 05, 2020

News Conference News PCR London Valves 2019

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

Michael O'Riordan

November 22, 2019

Presentation TCT 2019

TAVR With High Risk for Coronary Obstruction (Low Coronaries and Effaced Sinuses): Case Presentation and Management Strategies — How to Protect the Coronaries, BASILICA, etc.

Presenter: John Forrest

September 26, 2019

Presentation TCT 2019

Austria Presents: TAVR in a Patient With Anomalous Right Coronary Artery Origin From the Left Aortic Sinus

Presenter: Guy Friedrich

September 26, 2019

Advertisement

BASILICA, Chimney Stenting: No Clear Winner to Prevent TAVI Coronary Obstruction

Sizing Mismatch a Problem for Balloon-Expandable Valves in Small Annuli TAVI

TCT 742: Device closure of Ruptured Right Coronary Sinus of Valsalva Aneurysm (RSOV) in the subpulmonic right ventricle in an elderly female

Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’

Sinus Sequestration After TAVR With Coronary Protection: Diagnosis and Management

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

TCT 696: Coronary sinus reducer transfemoral extraction after intraprocedural device migration to pulmonary artery

His-bundle Pacing, TAVI Advice Debut in ESC’s Update to Pacing, CRT Guidelines

Low Mortality and Stroke Rates With BASILICA Pre-TAVI, Registry Shows

No Angina? No Benefit to PCI Pre-TAVR: ACTIVATION

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

TCT 464: Risk of Coronary Obstruction Due to Sinus Sequestration in Repeat Transcatheter Aortic Valve Replacement

Which TAVR Device Is Best? Review Tackles Optimal Selection

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion

ACS After TAVR a Unique Condition With Poor Prognosis

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

TAVR With High Risk for Coronary Obstruction (Low Coronaries and Effaced Sinuses): Case Presentation and Management Strategies — How to Protect the Coronaries, BASILICA, etc.

Austria Presents: TAVR in a Patient With Anomalous Right Coronary Artery Origin From the Left Aortic Sinus

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content